Loading…

Nondestructive prediction of the drug content of an aspirin suppository by near-infrared spectroscopy

Background: A suppository dosage form has a rapid effect on therapeutics, because it dissolves in the rectum, is absorbed in the bloodstream, and passes the hepatic metabolism. However, the dosage form is unstable, because a suppository is made in a semisolid form, and so it is not easy to mix the b...

Full description

Saved in:
Bibliographic Details
Published in:Drug development and industrial pharmacy 2010-07, Vol.36 (7), p.839-844
Main Authors: Otsuka, Eri, Abe, Hiroyuki, Aburada, Masaki, Otsuka, Makoto
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c471t-36a963e31724c36880f3a8e4b22c4e86714954e284660a7b310581aa0c0d510e3
cites cdi_FETCH-LOGICAL-c471t-36a963e31724c36880f3a8e4b22c4e86714954e284660a7b310581aa0c0d510e3
container_end_page 844
container_issue 7
container_start_page 839
container_title Drug development and industrial pharmacy
container_volume 36
creator Otsuka, Eri
Abe, Hiroyuki
Aburada, Masaki
Otsuka, Makoto
description Background: A suppository dosage form has a rapid effect on therapeutics, because it dissolves in the rectum, is absorbed in the bloodstream, and passes the hepatic metabolism. However, the dosage form is unstable, because a suppository is made in a semisolid form, and so it is not easy to mix the bulk drug powder in the base. Aim: This article describes a nondestructive method of determining the drug content of suppositories using near-infrared spectrometry (NIR) combined with chemometrics. Method: Suppositories (aspirin content: 1.8, 2.7, 4.5, 7.3, and 9.1%, w w) were produced by mixing an aspirin bulk powder with hard fat at 50 °C and pouring the melt mixture into a plastic mold (2.25 mL). NIR spectra of 12 calibration and 12 validation sample sets were recorded 5 times. A total of 60 spectral data were used as a calibration set to establish a calibration model to predict drug content with a partial least-squares (PLS) regression analysis. NIR data of the suppository samples were divided into two wave number ranges, 4000-12500 cm−1 (LR), and 5900-6300 cm−1 (SR). Calibration models for the aspirin content of the suppositories were calculated based on LR and SR ranges of second-derivative NIR spectra using PLS. Results: The models for LR and SR consisted of five and one principal components (PC), respectively. The plots of predicted values against actual values gave a straight line with regression coefficient constants of 0.9531 and 0.9749, respectively. The mean bias and mean accuracy of the calibration models were calculated based on the SR of variation data sets, and were lower than those of LR, respectively. Conclusion: Limiting the wave number of spectral data sets is useful to help understand the calibration model because of noise cancellation and to measure objective functions.
doi_str_mv 10.3109/03639040903532053
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3109_03639040903532053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733125486</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-36a963e31724c36880f3a8e4b22c4e86714954e284660a7b310581aa0c0d510e3</originalsourceid><addsrcrecordid>eNp9kM1O3DAUhS1EVabQB2BTeccq7fVvEtFNhfiphNpNWUce54Yxytip7YDy9ng0UKlC7cqWfc6nez9CThl8FgzaLyC0aEFCC0IJDkockBVTHCpVa35IVrv_qgTUEfmQ0gMA461S78kRByGkknJF8EfwPaYcZ5vdI9IpYu_KNXgaBpo3SPs431MbfEafd2_GU5MmF52naZ6mkFwOcaHrhXo0sXJ-iKZAaJrQ5hiSDdNyQt4NZkz48eU8JndXl78ubqrbn9ffL77dVlbWLFdCm1YLFKzm0grdNDAI06Bcc24lNrpmslUSeSO1BlOviwTVMGPAQq8YoDgmZ3vuFMPvuazVbV2yOI7GY5hTVwvBuJKNLkm2T9oyYoo4dFN0WxOXjkG3k9u9kVs6n17o83qL_Z_Gq80S-LoPFAkhbs1TiGPfZbOMIRYr3rq0Y_-bf_5XfYNmzBtbbHYPYY6-mPvPdM9gf5ol</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733125486</pqid></control><display><type>article</type><title>Nondestructive prediction of the drug content of an aspirin suppository by near-infrared spectroscopy</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><source>BSC - Ebsco (Business Source Ultimate)</source><creator>Otsuka, Eri ; Abe, Hiroyuki ; Aburada, Masaki ; Otsuka, Makoto</creator><creatorcontrib>Otsuka, Eri ; Abe, Hiroyuki ; Aburada, Masaki ; Otsuka, Makoto</creatorcontrib><description>Background: A suppository dosage form has a rapid effect on therapeutics, because it dissolves in the rectum, is absorbed in the bloodstream, and passes the hepatic metabolism. However, the dosage form is unstable, because a suppository is made in a semisolid form, and so it is not easy to mix the bulk drug powder in the base. Aim: This article describes a nondestructive method of determining the drug content of suppositories using near-infrared spectrometry (NIR) combined with chemometrics. Method: Suppositories (aspirin content: 1.8, 2.7, 4.5, 7.3, and 9.1%, w w) were produced by mixing an aspirin bulk powder with hard fat at 50 °C and pouring the melt mixture into a plastic mold (2.25 mL). NIR spectra of 12 calibration and 12 validation sample sets were recorded 5 times. A total of 60 spectral data were used as a calibration set to establish a calibration model to predict drug content with a partial least-squares (PLS) regression analysis. NIR data of the suppository samples were divided into two wave number ranges, 4000-12500 cm−1 (LR), and 5900-6300 cm−1 (SR). Calibration models for the aspirin content of the suppositories were calculated based on LR and SR ranges of second-derivative NIR spectra using PLS. Results: The models for LR and SR consisted of five and one principal components (PC), respectively. The plots of predicted values against actual values gave a straight line with regression coefficient constants of 0.9531 and 0.9749, respectively. The mean bias and mean accuracy of the calibration models were calculated based on the SR of variation data sets, and were lower than those of LR, respectively. Conclusion: Limiting the wave number of spectral data sets is useful to help understand the calibration model because of noise cancellation and to measure objective functions.</description><identifier>ISSN: 0363-9045</identifier><identifier>EISSN: 1520-5762</identifier><identifier>DOI: 10.3109/03639040903532053</identifier><identifier>PMID: 20334544</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage ; Anti-Inflammatory Agents, Non-Steroidal - analysis ; Aspirin - administration &amp; dosage ; Aspirin - analysis ; Drug Carriers ; Drug Compounding ; Drug content ; Drug Design ; Molecular Weight ; near-infrared spectrometry ; nondestructive prediction ; partial least-squares regression analysis ; Regression Analysis ; Spectroscopy, Near-Infrared ; Suppositories - chemistry ; suppository</subject><ispartof>Drug development and industrial pharmacy, 2010-07, Vol.36 (7), p.839-844</ispartof><rights>Informa UK, Ltd. 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-36a963e31724c36880f3a8e4b22c4e86714954e284660a7b310581aa0c0d510e3</citedby><cites>FETCH-LOGICAL-c471t-36a963e31724c36880f3a8e4b22c4e86714954e284660a7b310581aa0c0d510e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20334544$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Otsuka, Eri</creatorcontrib><creatorcontrib>Abe, Hiroyuki</creatorcontrib><creatorcontrib>Aburada, Masaki</creatorcontrib><creatorcontrib>Otsuka, Makoto</creatorcontrib><title>Nondestructive prediction of the drug content of an aspirin suppository by near-infrared spectroscopy</title><title>Drug development and industrial pharmacy</title><addtitle>Drug Dev Ind Pharm</addtitle><description>Background: A suppository dosage form has a rapid effect on therapeutics, because it dissolves in the rectum, is absorbed in the bloodstream, and passes the hepatic metabolism. However, the dosage form is unstable, because a suppository is made in a semisolid form, and so it is not easy to mix the bulk drug powder in the base. Aim: This article describes a nondestructive method of determining the drug content of suppositories using near-infrared spectrometry (NIR) combined with chemometrics. Method: Suppositories (aspirin content: 1.8, 2.7, 4.5, 7.3, and 9.1%, w w) were produced by mixing an aspirin bulk powder with hard fat at 50 °C and pouring the melt mixture into a plastic mold (2.25 mL). NIR spectra of 12 calibration and 12 validation sample sets were recorded 5 times. A total of 60 spectral data were used as a calibration set to establish a calibration model to predict drug content with a partial least-squares (PLS) regression analysis. NIR data of the suppository samples were divided into two wave number ranges, 4000-12500 cm−1 (LR), and 5900-6300 cm−1 (SR). Calibration models for the aspirin content of the suppositories were calculated based on LR and SR ranges of second-derivative NIR spectra using PLS. Results: The models for LR and SR consisted of five and one principal components (PC), respectively. The plots of predicted values against actual values gave a straight line with regression coefficient constants of 0.9531 and 0.9749, respectively. The mean bias and mean accuracy of the calibration models were calculated based on the SR of variation data sets, and were lower than those of LR, respectively. Conclusion: Limiting the wave number of spectral data sets is useful to help understand the calibration model because of noise cancellation and to measure objective functions.</description><subject>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - analysis</subject><subject>Aspirin - administration &amp; dosage</subject><subject>Aspirin - analysis</subject><subject>Drug Carriers</subject><subject>Drug Compounding</subject><subject>Drug content</subject><subject>Drug Design</subject><subject>Molecular Weight</subject><subject>near-infrared spectrometry</subject><subject>nondestructive prediction</subject><subject>partial least-squares regression analysis</subject><subject>Regression Analysis</subject><subject>Spectroscopy, Near-Infrared</subject><subject>Suppositories - chemistry</subject><subject>suppository</subject><issn>0363-9045</issn><issn>1520-5762</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kM1O3DAUhS1EVabQB2BTeccq7fVvEtFNhfiphNpNWUce54Yxytip7YDy9ng0UKlC7cqWfc6nez9CThl8FgzaLyC0aEFCC0IJDkockBVTHCpVa35IVrv_qgTUEfmQ0gMA461S78kRByGkknJF8EfwPaYcZ5vdI9IpYu_KNXgaBpo3SPs431MbfEafd2_GU5MmF52naZ6mkFwOcaHrhXo0sXJ-iKZAaJrQ5hiSDdNyQt4NZkz48eU8JndXl78ubqrbn9ffL77dVlbWLFdCm1YLFKzm0grdNDAI06Bcc24lNrpmslUSeSO1BlOviwTVMGPAQq8YoDgmZ3vuFMPvuazVbV2yOI7GY5hTVwvBuJKNLkm2T9oyYoo4dFN0WxOXjkG3k9u9kVs6n17o83qL_Z_Gq80S-LoPFAkhbs1TiGPfZbOMIRYr3rq0Y_-bf_5XfYNmzBtbbHYPYY6-mPvPdM9gf5ol</recordid><startdate>20100701</startdate><enddate>20100701</enddate><creator>Otsuka, Eri</creator><creator>Abe, Hiroyuki</creator><creator>Aburada, Masaki</creator><creator>Otsuka, Makoto</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100701</creationdate><title>Nondestructive prediction of the drug content of an aspirin suppository by near-infrared spectroscopy</title><author>Otsuka, Eri ; Abe, Hiroyuki ; Aburada, Masaki ; Otsuka, Makoto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-36a963e31724c36880f3a8e4b22c4e86714954e284660a7b310581aa0c0d510e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - administration &amp; dosage</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - analysis</topic><topic>Aspirin - administration &amp; dosage</topic><topic>Aspirin - analysis</topic><topic>Drug Carriers</topic><topic>Drug Compounding</topic><topic>Drug content</topic><topic>Drug Design</topic><topic>Molecular Weight</topic><topic>near-infrared spectrometry</topic><topic>nondestructive prediction</topic><topic>partial least-squares regression analysis</topic><topic>Regression Analysis</topic><topic>Spectroscopy, Near-Infrared</topic><topic>Suppositories - chemistry</topic><topic>suppository</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Otsuka, Eri</creatorcontrib><creatorcontrib>Abe, Hiroyuki</creatorcontrib><creatorcontrib>Aburada, Masaki</creatorcontrib><creatorcontrib>Otsuka, Makoto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Drug development and industrial pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Otsuka, Eri</au><au>Abe, Hiroyuki</au><au>Aburada, Masaki</au><au>Otsuka, Makoto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nondestructive prediction of the drug content of an aspirin suppository by near-infrared spectroscopy</atitle><jtitle>Drug development and industrial pharmacy</jtitle><addtitle>Drug Dev Ind Pharm</addtitle><date>2010-07-01</date><risdate>2010</risdate><volume>36</volume><issue>7</issue><spage>839</spage><epage>844</epage><pages>839-844</pages><issn>0363-9045</issn><eissn>1520-5762</eissn><abstract>Background: A suppository dosage form has a rapid effect on therapeutics, because it dissolves in the rectum, is absorbed in the bloodstream, and passes the hepatic metabolism. However, the dosage form is unstable, because a suppository is made in a semisolid form, and so it is not easy to mix the bulk drug powder in the base. Aim: This article describes a nondestructive method of determining the drug content of suppositories using near-infrared spectrometry (NIR) combined with chemometrics. Method: Suppositories (aspirin content: 1.8, 2.7, 4.5, 7.3, and 9.1%, w w) were produced by mixing an aspirin bulk powder with hard fat at 50 °C and pouring the melt mixture into a plastic mold (2.25 mL). NIR spectra of 12 calibration and 12 validation sample sets were recorded 5 times. A total of 60 spectral data were used as a calibration set to establish a calibration model to predict drug content with a partial least-squares (PLS) regression analysis. NIR data of the suppository samples were divided into two wave number ranges, 4000-12500 cm−1 (LR), and 5900-6300 cm−1 (SR). Calibration models for the aspirin content of the suppositories were calculated based on LR and SR ranges of second-derivative NIR spectra using PLS. Results: The models for LR and SR consisted of five and one principal components (PC), respectively. The plots of predicted values against actual values gave a straight line with regression coefficient constants of 0.9531 and 0.9749, respectively. The mean bias and mean accuracy of the calibration models were calculated based on the SR of variation data sets, and were lower than those of LR, respectively. Conclusion: Limiting the wave number of spectral data sets is useful to help understand the calibration model because of noise cancellation and to measure objective functions.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>20334544</pmid><doi>10.3109/03639040903532053</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0363-9045
ispartof Drug development and industrial pharmacy, 2010-07, Vol.36 (7), p.839-844
issn 0363-9045
1520-5762
language eng
recordid cdi_crossref_primary_10_3109_03639040903532053
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list); BSC - Ebsco (Business Source Ultimate)
subjects Anti-Inflammatory Agents, Non-Steroidal - administration & dosage
Anti-Inflammatory Agents, Non-Steroidal - analysis
Aspirin - administration & dosage
Aspirin - analysis
Drug Carriers
Drug Compounding
Drug content
Drug Design
Molecular Weight
near-infrared spectrometry
nondestructive prediction
partial least-squares regression analysis
Regression Analysis
Spectroscopy, Near-Infrared
Suppositories - chemistry
suppository
title Nondestructive prediction of the drug content of an aspirin suppository by near-infrared spectroscopy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T15%3A36%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nondestructive%20prediction%20of%20the%20drug%20content%20of%20an%20aspirin%20suppository%20by%20near-infrared%20spectroscopy&rft.jtitle=Drug%20development%20and%20industrial%20pharmacy&rft.au=Otsuka,%20Eri&rft.date=2010-07-01&rft.volume=36&rft.issue=7&rft.spage=839&rft.epage=844&rft.pages=839-844&rft.issn=0363-9045&rft.eissn=1520-5762&rft_id=info:doi/10.3109/03639040903532053&rft_dat=%3Cproquest_cross%3E733125486%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c471t-36a963e31724c36880f3a8e4b22c4e86714954e284660a7b310581aa0c0d510e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733125486&rft_id=info:pmid/20334544&rfr_iscdi=true